Journal
Journal of the American College of Cardiology
Publication Date
5-28-2024
Volume
83
Issue
21
First Page
2037
Last Page
2048
Document Type
Open Access Publication
DOI
10.1016/j.jacc.2024.03.387
Rights and Permissions
Maron MS, Mahmod M, Abd Samat AH, Choudhury L, Massera D, Phelan DMJ, Cresci S, Martinez MW, Masri A, Abraham TP, Adler E, Wever-Pinzon O, Nagueh SF, Lewis GD, Chamberlin P, Patel J, Yavari A, Dehbi HM, Sarwar R, Raman B, Valkovič L, Neubauer S, Udelson JE, Watkins H. Safety and Efficacy of Metabolic Modulation With Ninerafaxstat in Patients With Nonobstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2024 May 28;83(21):2037-2048. doi: 10.1016/j.jacc.2024.03.387 This article is available under the Creative Commons CC-BY-NC-ND license and permits non-commercial use of the work as published, without adaptation or alteration provided the work is fully attributed.
Recommended Citation
Maron, Martin S; Cresci, Sharon; and et al., "Safety and efficacy of metabolic modulation with ninerafaxstat in patients with nonobstructive hypertrophic cardiomyopathy." Journal of the American College of Cardiology. 83, 21. 2037 - 2048. (2024).
https://digitalcommons.wustl.edu/oa_4/5373
Department
ICTS (Institute of Clinical and Translational Sciences)
